107 related articles for article (PubMed ID: 8575036)
1. Studies on antiulcer agents. III. Plausible mechanism of antisecretory action of ethyl 2[(1H-benzimadazol-2-yl)sulfinylmethyl]-4-dimethylamino- 5-pyrimidinecarboxylate, an H+/K(+)-ATPase inhibitor, based on its reaction with thiols.
Terashima K; Muraoka O; Ono M
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1985-91. PubMed ID: 8575036
[TBL] [Abstract][Full Text] [Related]
2. Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activity.
Terashima K; Shimamura H; Kawase A; Tanaka Y; Uenishi K; Kimura I; Ishizuka Y; Sato M
Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):166-8. PubMed ID: 7895305
[TBL] [Abstract][Full Text] [Related]
3. Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolines and related compounds.
Uchida M; Chihiro M; Morita S; Kanbe T; Yamashita H; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2109-16. PubMed ID: 2557164
[TBL] [Abstract][Full Text] [Related]
4. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds.
Uchida M; Chihiro M; Morita S; Yamashita H; Yamasaki K; Kanbe T; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1575-86. PubMed ID: 2170036
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiulcer activities of novel 2-[(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H- benzimidazole analogues.
Yamada S; Goto T; Shimanuki E; Narita S
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):718-20. PubMed ID: 8004722
[TBL] [Abstract][Full Text] [Related]
7. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
[TBL] [Abstract][Full Text] [Related]
9. The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.
Lorentzon P; Eklundh B; Brändström A; Wallmark B
Biochim Biophys Acta; 1985 Jul; 817(1):25-32. PubMed ID: 2988621
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
11. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the inhibitory action of leminoprazole against rabbit gastric H+,K(+)-ATPase].
Masuda M; Uchida A; Matsukura H; Kamishiro T
Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):325-35. PubMed ID: 7959423
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of gastric antisecretory effect of SCH 28080.
Beil W; Hackbarth I; Sewing KF
Br J Pharmacol; 1986 May; 88(1):19-23. PubMed ID: 3011171
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents.
Shafik RM; El-Din SA; Eshba NH; El-Hawash SA; Desheesh MA; Abdel-Aty AS; Ashour HM
Pharmazie; 2004 Dec; 59(12):899-905. PubMed ID: 15638075
[TBL] [Abstract][Full Text] [Related]
15. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
Tomiyama Y; Morii M; Takeguchi N
Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
[TBL] [Abstract][Full Text] [Related]
16. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H
Rajesh R; Manikandan A; Sivakumar A; Ramasubbu C; Nagaraju N
Eur J Med Chem; 2017 Oct; 139():454-460. PubMed ID: 28818769
[TBL] [Abstract][Full Text] [Related]
17. The gastric H,K ATPase as a drug target: past, present, and future.
Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
[TBL] [Abstract][Full Text] [Related]
18. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Im WB; Blakeman DP; Davis JP
Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
[TBL] [Abstract][Full Text] [Related]
19. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
Morozov IA
Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
[TBL] [Abstract][Full Text] [Related]
20. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]